A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma

Condition:   Asthma
Intervention:   Drug: ABS eMDPI
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.